Abstract
Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used in the treatment of pain, fever and inflammation. For these agents inhibition of prostaglandin synthesis via inhibition of cyclooxygenases (COX) is considered to be their principle mode of action.1 However, inhibition of prostaglandin synthesis alone may not account for all effects of NSAIDs. There is no satisfying correlation between inhibition of prostaglandin synthesis and antinociceptive (analgesic) effects of some of these agents.2 Weak inhibitors of prostaglandin synthesis, e. g. salicylic acid exert potent antinociceptive effects.3 Such observations question the conventual concept that NSAIDs act exclusively by inhibiting prostaglandin synthesis. However, neither the cellular target nor cell signaling pathways possibly involved in the antinociceptive effect of weak prostaglandin inhibitors have been identified yet.
The first two authors have contributed equally
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
J.R. Vane. Towards a better aspirin, Nature 367: 215 (1994).
K. McCormack and K. Brune, Dissociation between antinociceptive and antiinflammatory effects of the nonsteroidal anti-inflammatory drugs, Drugs 41: 533 (1991).
K. Brune, W.S. Beck, G. Geisslinger, S. Menzel-Soglowek, B.M. Peskar, and B.A. Peskar, Aspirin like drugs may block pain independently of prostaglandin synthesis inhibition, Experientia 47: 257 (1991).
E. Kopp, and S. Gosh, Inhibition of NF-κB by sodium salicylate and aspirin, Science 265: 956 (1994).
R. Sen, and D. Baltimore, Multiple nuclear factors interact with the immunglobulin enhancer sequences, Cell 46: 705 (1986).
E.B. Kopp, and S. Gosh, NF-κB and rel proteins in innate immunity, Adv. Immunol. 58: 1 (1995).
A.S. Baldwin Jr. The NF-κB and IκB proteins: new discoveries and insights, Annu. Rev. Immunol. 14: 649 (1996).
Z.J. Chen, L. Parent, and T. Maniatis, Site specific phosphorylation of IκBα by a novel ubiquitination-dependent protein kinase activity, Cell 84: 853 (1996).
G. Geisslinger, G.S.H. Ferreira, S. Menzel, D. Schlott, and K. Brune, Antinociceptive actions of R (-)-flurbiprofen-a non-cyclooxygenase inhibiting 2-arylpropionic acid-in rats, Life Sci. 54.PL 173 (1994).
P.M. Brooks, and R.O. Day, Nonsteroidal anti-inflammatory drugs-differences and similarities, N. Engl. J. Med. 324: 1716 (1991).
A.A. Beg, and A.S. Baldwin, The IκB proteins: multifunctional regulators of Rel/NF-κB transcription factors, Genes Dev. 7: 2064 (1993).
A.A. Beg, T.S. Finco, P.V. Nantermet, and A.S. Baldwin Jr., Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of IκBα: a mechanism for NF-κB activation, Mol. Cell. Biol. 13: 3301 (1993).
E.F. Davies, and G.S. Avery, Ibuprofen: a review of its pharmacological properties and therapeutic efficacy in rheumatic disorders, Drugs 2: 416 (1971).
R.C. Glass, and A.J. Swannell, Concentrations of ibuprofen in serum and synovial fluid from patients with arthritis, Br. J. Pharmacol. 6: 453P (1978).
I.M. Verma, J.K. Stevenson, E.M. Schwarz, D. van Antwerp, and S. Miyamoto, Rel/NF-κB/IκB family: intimitate tales of association and dissociation, Genes Dev. 9: 2723 (1996).
J. Feuillard, H. Gouy, G. Bismuth, L.E. Lee, P. Debre, and M. Körner, NF-κB activation by tumor necrosis factor α in the Jurkat T-cell line is independent of protein kinase A, protein kinase C, and Ca2+-regulated kinases, Cytokine 3: 257 (1991).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media New York
About this chapter
Cite this chapter
Scheuren, N., Bang, H., Münster, T., Brune, K., Pahl, A. (1997). Weak Inhibitors of Cyclooxygenases May Exert Their Antinociceptive Effect by Modulation of Transcription Factors. In: Sinzinger, H., Samuelsson, B., Vane, J.R., Paoletti, R., Ramwell, P., Wong, P.YK. (eds) Recent Advances in Prostaglandin, Thromboxane, and Leukotriene Research. Advances in Experimental Medicine and Biology, vol 433. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-1810-9_9
Download citation
DOI: https://doi.org/10.1007/978-1-4899-1810-9_9
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-1812-3
Online ISBN: 978-1-4899-1810-9
eBook Packages: Springer Book Archive